Latest Stock Split Details
Key information about Poniard Pharmaceuticals, Inc.'s most recent stock split
Split Date: 2011-11-23
Split Ratio: 1:40
Price Before Split: $0.15
Price After Split: $0.00
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 40.00 times fewer shares (a 1:40 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Poniard Pharmaceuticals, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2011-11-23 | 1:40 | Yes | $0.15 | $0.00 |
| 2006-09-25 | 1:6 | Yes | $0.13 | $0.02 |
| 1993-12-14 | 1:4 | Yes | $0.50 | $0.12 |
About Poniard Pharmaceuticals, Inc.
Company overview and industry information
Poniard Pharmaceuticals, Inc. (PARD) operates in the Biotechnology industry. The recent 1-for-40 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Poniard Pharmaceuticals, Inc. Summary